Notice of Intent- Surgical Aspirator Liposuction System

Award Notice Posted

Solicitation number
N6264518RCES024
Agency
Awarded
to Valeant Pharmaceuticals International Corporation
Set-aside
No set-aside

Opportunity facts

Contract number
N6264518P2013 Federal contract award
NAICS code
339112 Surgical and Medical Instrument Manufacturing
PSC
Not on record
Place of performance
Naval Medical Center (NMC) Portsmouth 620 John Paul Jones Circle Portsmouth, Virginia 23708, United States

Notice details come from SAM.gov. Updated .

Notice text

2 versions

Update #2 · Latest ·

 


The Naval Medical Logistics Command intends to award a sole source contract (IAW FAR 13.106-1(b)(1)) to Valeant Pharmaceuticals North America LLC., 400 Somerset Corporate Boulevard, Bridgewater, NJ. 08007 as the only responsible source that can provide a surgical aspirator liposuction system that is a single-integrated platform which utilizes ultrasound energy for infusion, emulsification, and aspiration for body sculpting procedures.


Vendor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor, or authorized reseller for the proposed equipment/system, such that OEM warranty and service are provided and maintained by the OEM.  All software licensing, warranty, and service associated with the equipment/system shall be in accordance with the OEM terms and conditions.


The system, including claims made for the product, shall be compliant with Food and Drug Administration (FDA) regulations, with respect to marketing and delivering medical products for use in the United States of America. These requirements shall apply even if delivery is requested outside of the United States of America. The system shall be installed in compliance with OSHA requirements.


This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement.  Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work.  Capability statements shall not exceed 1 (8.5 x 11 inch) page using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government.  A request for documentation or additional information will not be considered as an affirmative response.  A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government.  Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.


Capability statements are due by 11:00 AM Eastern Time, 28 March 2018. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: mindy.r.franks.civ@mail.mil.


 

Update #1 ·

The Naval Medical Logistics Command intends to award a sole source contract (IAW FAR 13.106-1(b)(1)) to Solta Medical, Inc., 7031 Koll Center Parkway, Suite 260, Pleasanton, CA. 94566 as the only responsible source that can provide a surgical aspirator liposuction system that is a single-integrated platform which utilizes ultrasound energy for infusion, emulsification, and aspiration for body sculpting procedures.
Vendor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor, or authorized reseller for the proposed equipment/system, such that OEM warranty and service are provided and maintained by the OEM. All software licensing, warranty, and service associated with the equipment/system shall be in accordance with the OEM terms and conditions.
The system, including claims made for the product, shall be compliant with Food and Drug Administration (FDA) regulations, with respect to marketing and delivering medical products for use in the United States of America. These requirements shall apply even if delivery is requested outside of the United States of America. The system shall be installed in compliance with OSHA requirements.
This notice of intent is not a request for competitive proposals and no solicitation document exists for the requirement. Sources interested in responding to this notice are required to submit a capability statement that includes management and technical data and cost information, in sufficient detail and with convincing evidence that clearly demonstrates the capability to perform the required work. Capability statements shall not exceed 1 (8.5 x 11 inch) page using a font size no smaller than 10-point. All capability statements received by the due date of this notice will be considered by the Government. A request for documentation or additional information will not be considered as an affirmative response. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or to proceed with a sole source contract.
Capability statements are due by 9:00 AM Eastern Time, 21 February 2018. Capability statements shall be submitted by e-mail ONLY as a Microsoft Word or Adobe PDF attachment to the following address: mindy.r.franks.civ@mail.mil.

 

Notice history

Notice Type Posted
Vaser Lipo SyStem Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors